IGM ANTIBODIES TO CYTOMEGALOVIRUS (CMV IGM) 04784618190

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2016-05-20 for IGM ANTIBODIES TO CYTOMEGALOVIRUS (CMV IGM) 04784618190 manufactured by Roche Diagnostics.

Event Text Entries

[45596467] This event occurred in (b)(6).
Patient Sequence No: 1, Text Type: N, H10


[45596468] The customer stated that they received erroneous results for two patient samples tested for igm antibodies to cytomegalovirus (cmv igm) on an e601 analyzer. It was asked, but it is not known if the erroneous results were reported outside of the laboratory. The first sample initially resulted as 0. 448 coi (non-reactive) on the e601 analyzer. The sample was repeated at a different laboratory on an abbott architect analyzer on (b)(6) 2016, resulting as 1. 90 ratio (positive). The sample was also repeated on the e601 analyzer on (b)(6) 2016, resulting as 0. 462 coi (non-reactive). The second sample, from a (b)(6) female, initially resulted as 0. 564 coi (non-reactive) on the e601 analyzer on (b)(6) 2016. The sample was repeated at a different laboratory on an abbott architect analyzer on (b)(6) 2016, resulting as 1. 10 ratio (positive). The patients were not adversely affected. The e601 analyzer serial number was asked for, but not provided.
Patient Sequence No: 1, Text Type: D, B5


[54905243] A specific root cause could not be determined based on the provided information. Samples from the first patient were provided for investigation. A sample from the second patient was not available for investigation. Investigation of the first patient sample was able to confirm the customer's results. The sample showed (b)(6), but was still (b)(6) the cut-off for the elecsys cmv igm assay. The sample was (b)(6) when tested with the recomline cmv igm assay. The (b)(6) of the detected antibodies suggest that the first patient may have encountered a primary infection with (b)(6) 18-20 weeks prior to the sampling on (b)(6) 2016. The previous sample from this patient measured on (b)(6) 2015 did not show (b)(6) in the performed assays, indicating that the time point of infection must have been in close proximity to the first sampling date. Apparently, at this earlier time point significant antibody titers had not formed yet. Moreover, the later sample shows an only (b)(6) igm titer suggesting that this patient developed a (b)(6) response only, which renders early detection challenging. Alternatively, the maturation of igg antibodies might occur faster than average in this particular patient and the time point of primary infection was between the two samplings. No medical device problem was found.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1823260-2016-00665
MDR Report Key5669559
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2016-05-20
Date of Report2016-08-16
Date of Event2016-04-05
Date Mfgr Received2016-05-10
Date Added to Maude2016-05-20
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNA MICHAEL LESLIE
Manufacturer Street9115 HAGUE ROAD NA
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175214343
Manufacturer G1ROCHE DIAGNOSTICS GMBH
Manufacturer StreetSANDHOFERSTRASSE 116 NA
Manufacturer CityMANNHEIM (BADEN-WURTTEMBERG) 68305
Manufacturer CountryGM
Manufacturer Postal Code68305
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameIGM ANTIBODIES TO CYTOMEGALOVIRUS (CMV IGM)
Generic NameENZYME LINKED IMMUNOABSORBENT ASSAY, CYTOMEGALOVIRUS
Product CodeLFZ
Date Received2016-05-20
Model NumberNA
Catalog Number04784618190
Lot Number187017
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD NA INDIANAPOLIS IN 462500457 US 462500457


Patients

Patient NumberTreatmentOutcomeDate
10 2016-05-20

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.